Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity - Test2 - elhamkhani - TriplyDB

Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity

Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity

http://www.wikidata.org/entity/Q21144862

about

Extremely High Mutation Rate of HIV-1 In Vivo Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization.A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial.The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population.Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis.Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches.Creation of chimeric human/rabbit APOBEC1 with HIV-1 restriction and DNA mutation activities.APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes APOBEC3 proteins can copackage and comutate HIV-1 genomes.The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity.APOBECs and virus restriction.The APOBEC Protein Family: United by Structure, Divergent in Function.The Structural Interface between HIV-1 Vif and Human APOBEC3H.Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population.A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.The KT Jeang Retrovirology prize 2017: Michael Emerman.APOBEC Enzymes as Targets for Virus and Cancer Therapy.The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans.Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control.Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients.Understanding the Structure, Multimerization, Subcellular Localization and mC Selectivity of a Genomic Mutator and Anti-HIV Factor APOBEC3H.SIVmac239 Vif and Human APOBEC3B Interactions Resemble Those Between HIV-1 Vif and Human APOBEC3G.Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G.Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease

P2860

Q28548089-F0AFCE54-55BB-41E3-AEEE-4149E49076F6 Q33558327-030912F2-7911-4019-A8BF-A479D48922D0 Q33651576-F3522030-C5EE-4F50-BA15-8E4740DB302D Q33699581-5874625C-9BC9-460B-BA6F-1F9F50CE689F Q35845726-451E8F10-ACCC-4016-84A5-6BDDF8981925 Q36149915-B9AF3C82-0D91-4D55-BC69-F5D91D9ACB11 Q36276957-CCF7AD40-E607-48F2-B465-96FE42FB466D Q36283884-2056AA74-7D2A-499E-A798-EF4402BB2D54 Q36384317-C5696118-1796-4B58-9964-93758CE55E54 Q36438515-9DEF9B59-2889-4F25-8ABA-A11B9957A0F4 Q36811931-D679324F-B815-4751-8094-DFF392FA52AC Q37047737-469FA522-C30A-43E8-AE14-E478D1A3A8B5 Q37264399-32D6018F-7697-4021-8D8B-16FAC8586CFE Q37281847-E6877719-BF57-4E56-AE0E-E033D6F01E9D Q37518508-8B37D773-38DB-466C-B147-60EB6CFA4CC6 Q38394187-9A5CA9DA-0DBA-415A-AFA3-7918D0463DD4 Q38860803-06B5E667-F7E9-47D7-B5EF-A6DB645FDEB0 Q39056653-9A2F75BE-C4F5-42C0-94E6-2F65A00B5288 Q40618088-598CC3FC-C739-4CEC-9C84-32351B9CDFAE Q40913460-C96AE214-3179-4120-B9BB-D7B6A08C0CEE Q40941381-512FF12B-E6B1-4B1B-A460-14F42EB688B3 Q42335670-C659E84F-C692-4E53-A065-47E30D8F274D Q45324625-0CA38B30-449F-4036-9DF3-DCB7367DBFC6 Q47207734-7FAAC1F4-DB33-496D-84B2-FAB088797348 Q47265189-F14E3CBF-E3B5-4ABE-894F-489027EC8548 Q47548056-442364BA-618C-448A-A061-BB1BBFF3F774 Q47553808-A2B50CD9-BEBC-440C-816D-9579A741E1C1 Q52371380-20F98ECC-D41D-4858-AA86-0A623C87EF24 Q52606462-703F1752-3C19-42C6-805A-631E9BFD7BAC Q54237606-8266BF26-BA46-4530-A3AF-F0F93473DB3C Q55033661-9C40E557-2321-4CFD-9121-A9F9B5376819 Q57295397-EBFC7B01-47F3-48AB-9990-5234317BAC65

P2860

Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity

http://www.wikidata.org/entity/Q21144862

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Natural polymorphisms in human ...... utation levels and infectivity

@ast

Natural polymorphisms in human ...... utation levels and infectivity

@en

Natural polymorphisms in human ...... utation levels and infectivity

@en-gb

Natural polymorphisms in human ...... utation levels and infectivity

@nl

type

label

Natural polymorphisms in human ...... utation levels and infectivity

@ast

Natural polymorphisms in human ...... utation levels and infectivity

@en

Natural polymorphisms in human ...... utation levels and infectivity

@en-gb

Natural polymorphisms in human ...... utation levels and infectivity

@nl

altLabel

Natural Polymorphisms in Human ...... utation Levels and Infectivity

@en

prefLabel

Natural polymorphisms in human ...... utation levels and infectivity

@ast

Natural polymorphisms in human ...... utation levels and infectivity

@en

Natural polymorphisms in human ...... utation levels and infectivity

@en-gb

Natural polymorphisms in human ...... utation levels and infectivity

@nl

P1433

Q21144862-867F960A-659F-45B7-BD21-5BB2524ADF11

P1476

Q21144862-ACA79AC2-C988-487E-8FA9-D542F90B4F50

P2093

Q21144862-0B8F3045-7A31-4367-A401-5E7BE48603C1

Q21144862-4A2E5F53-76CC-4DF5-8D17-181AA1E7B69D

Q21144862-5974993D-3B9F-4ED7-A797-A733EB8F6A90

Q21144862-6A69CD29-A0B1-4221-B0F2-BC66385FCD99

Q21144862-834230DC-F1C4-49E5-BA19-91043B11498D

Q21144862-88CBAE6A-7469-4F70-875B-ABA5E138BAED

Q21144862-C5DE2B12-21E6-470F-B746-5A87C7A81B94

Q21144862-E422AF76-9B45-4665-91C8-6452197F3B8B

P2860

Q21144862-0DB6D4D9-9B6B-4AF3-8178-F29EA9EE28F4

Q21144862-175FE08A-1DBB-4F7F-BBB5-7C8DB27280A9

Q21144862-18755847-2655-4A83-BE52-EF7496C8EC87

Q21144862-1A61B873-FB13-47EC-85A2-C86F62EF3F7E

Q21144862-35116D73-7786-4FE7-97BD-E47A6E1668A2

Q21144862-3571511E-3A31-4E54-B90E-29CD2D4F6CA0

Q21144862-36DD2F8F-430D-4007-A057-4B336D7BE36D

Q21144862-3A261B75-5DD2-4872-9C4F-601F4B011F2D

Q21144862-3D695FB7-8430-4EA3-8704-E811E06E65C4

Q21144862-46345F91-0F00-4EF2-91A2-E2B45618D22A

P304

Q21144862-5D832260-A927-4F19-B421-BB5C1F9AED3A

P31

Q21144862-E77F7FFA-7345-43E2-AE0D-F4C10E6FE90B

P3181

Q21144862-CB6C4AB3-8C59-4778-8DCC-4506789602A6

P356

Q21144862-4726BFB5-A684-4CE7-B86E-201C8BAC24E6

P407

Q21144862-F0163EE0-F351-4DF7-BED0-8762BD219D85

P433

Q21144862-8EB13A6B-3314-403B-954E-2E4C3F0F44D6

P478

Q21144862-0EBD222B-C8AB-4FB3-A472-D79D84447255

P50

Q21144862-28747198-7577-4EFE-A060-C1508AA33B66

Q21144862-D58722EF-4577-42F8-9FD2-0DD6D8BB3720

P577

Q21144862-60B5573F-CA48-4B62-9067-B1B33E82AE0C

P5875

Q21144862-1375CA8C-B929-44ED-A3A6-204E75618867

P698

Q21144862-0AF12F13-2CEF-4187-9D91-5D8C4974B03F

P921

Q21144862-10F0895E-DD8E-4D96-98DA-9EF490AD7015

P932

Q21144862-3BA0A5A8-5738-41EB-9AF7-EB93E4CF67A0

P3181

P356

JOURNAL.PGEN.1004761

P1433

P1476

Natural polymorphisms in human ...... utation levels and infectivity

@en

P2093

Cavan Reilly

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Luengas

http://www.w3.org/2001/XMLSchema#string

Emily K Law

http://www.w3.org/2001/XMLSchema#string

Eric W Refsland

http://www.w3.org/2001/XMLSchema#string

Judd F Hultquist

http://www.w3.org/2001/XMLSchema#string

Nadine M Shaban

http://www.w3.org/2001/XMLSchema#string

Terumasa Ikeda

http://www.w3.org/2001/XMLSchema#string

William L Brown

http://www.w3.org/2001/XMLSchema#string

P2860

HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC

An integrated map of genetic variation from 1,092 human genomes

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction

Antiretroelement activity of APOBEC3H was lost twice in recent human evolution

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

The restriction factors of human immunodeficiency virus

An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

P304

e1004761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3430133

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PGEN.1004761

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Reuben S Harris

Michael Emerman

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270653358

http://www.w3.org/2001/XMLSchema#string

P698

25411794

http://www.w3.org/2001/XMLSchema#string

P921

P932

4238949

http://www.w3.org/2001/XMLSchema#string